Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.
about
Angiotensin receptors, autoimmunity, and preeclampsiaPreeclampsia: long-term consequences for vascular healthElucidating immune mechanisms causing hypertension during pregnancyThe renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?Pregnant rats treated with a high-fat/prooxidant Western diet with ANG II and TNF-α are resistant to elevations in blood pressure and renal oxidative stressEffects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancyRegulation of the Anti-Inflammatory Cytokines Interleukin-4 and Interleukin-10 during Pregnancy.Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemiaTissue transglutaminase contributes to the pathogenesis of preeclampsia and stabilizes placental angiotensin receptor type 1 by ubiquitination-preventing isopeptide modification.Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsiaB cells: the old new players in reproductive immunology.Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndromeThe matrix metalloproteases and endothelin-1 in infection-associated preterm birth.Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia.TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion.Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant womenCD4(+) T Cells Play a Critical Role in Mediating Hypertension in Response to Placental Ischemia.Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy.Reduced uterine perfusion pressure induces hypertension in the pregnant mouse.Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia.Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancyFull-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?Chronic hyperleptinemia results in the development of hypertension in pregnant rats.Preeclampsia: multiple approaches for a multifactorial diseasePotential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsiaRecombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice.The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia.Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies.Is preeclampsia an autoimmune disease?A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model.Role of sex steroids in modulating tumor necrosis factor alpha-induced changes in vascular function and blood pressureGenetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats
P2860
Q24605647-ED1281BD-83A0-44DA-A2FD-97E8260C2A94Q26800272-30E3827F-B3E3-4F83-8C27-5E2CA7EA3928Q26852668-66728922-CAA7-41F0-B3D6-3D98622DA5A7Q27003301-C781E881-94A2-45A1-A42A-4CD10F150C09Q28395340-C5C843DD-27D8-4144-B340-904DD70F418FQ33607465-B2161E1B-EE78-454C-AE02-CF3561FBA0A8Q33664998-7BBC5329-57A3-4226-8E3D-E1282765D303Q33665037-C8C66EBD-8284-4116-B2E4-2BB6E8CAC3FCQ33666742-6530D57F-0C0F-46C1-AD3F-D07D455DDDA0Q33736407-627377F1-409F-4491-A17F-BCE6AACB5289Q33737470-22754A06-7087-4C6E-B3C8-56C4AD093CC7Q33748650-82A82756-0E35-44E9-8A2E-52DB3D4DF0F1Q33789436-E76F26EE-5DC5-403A-B89F-06E402E05AACQ33793455-EC81C3FC-0020-4638-B9B5-C24DA5E4E8E4Q33799413-BEE1670A-A96C-44D0-86F8-D31E0D5351A5Q34025660-14C96511-709D-423F-B9B8-58A40991C159Q34035600-8CDDEE6D-CD52-4EAC-AD47-2B15B2059A95Q34154805-3DAF4A67-8080-4B99-8B55-96F18ED438B8Q34305595-77B178F1-56EE-4229-9E36-69C2DE447DC1Q34495512-95A7C728-EF24-4BB0-A78A-86A5B3398C92Q34508485-F62E792B-CBB3-41F0-8A7C-40A3990F2180Q34533218-C37C4727-C1C6-4C37-8510-DA2033108BFCQ34627421-60269EDD-4204-4D24-B5A1-EF1413408009Q34785813-89037AA4-103F-48DC-B591-936AAC4F0045Q35029700-DB8BF7D0-EEA5-4127-9355-54A5ECEF27CEQ35130793-4B2B3F33-D832-405F-AF37-D6B4ABECE4E6Q35362708-CB3E800B-D416-4614-8278-572BEC5CA9AEQ35581520-E50886A7-01FD-4BCB-B322-045A89D2C639Q35622378-15E991D3-8F4F-4C6A-A998-8BF96B9B5514Q35665007-2CC5A442-B50A-4CD3-BC80-6FE7200414BEQ35681821-725BDFD7-8920-44CB-885D-B479074464E6Q35683468-AB33904E-8DFB-4BD7-9B65-B5BCD1766F45Q35701236-61CA87CC-3A9C-4D6B-9E23-48DA17D8DE1CQ35817935-B4F40584-E1CB-4B2C-9473-FB2DEE2C29A7Q35860239-FB415154-CE06-41D2-BCAD-A27383C02E7FQ36050775-38D67B84-7163-4D50-BE3C-B896F040DBB0Q36115311-BA0A6211-8DBE-4A46-B110-76566728DD26Q36168798-E0124BC0-EF3B-4261-9273-A6E5F1F7D4D8Q36268948-64404279-BBAB-4373-A857-9B3F23F1CACDQ36339273-D21D16A6-DFCE-45CF-A1AD-4539CB6C7A2B
P2860
Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Hypertension produced by reduc ...... f tumor necrosis factor-alpha.
@en
Hypertension produced by reduc ...... f tumor necrosis factor-alpha.
@nl
type
label
Hypertension produced by reduc ...... f tumor necrosis factor-alpha.
@en
Hypertension produced by reduc ...... f tumor necrosis factor-alpha.
@nl
prefLabel
Hypertension produced by reduc ...... f tumor necrosis factor-alpha.
@en
Hypertension produced by reduc ...... f tumor necrosis factor-alpha.
@nl
P2093
P1433
P1476
Hypertension produced by reduc ...... f tumor necrosis factor-alpha.
@en
P2093
B Babbette D LaMarca
Barbara T Alexander
Joey P Granger
Kathy Cockrell
William A Bennett
P304
P356
10.1161/01.HYP.0000175476.26719.36
P407
P577
2005-09-06T00:00:00Z